Emcure Pharmaceuticals Reports Strong Q4 FY25 Results with 19% Revenue Growth and 63% Increase in Profit After Tax
MM Desk
May 23, 2025
Emcure Pharmaceuticals has announced its consolidated financial results for the fourth quarter and full year
